NVO

NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 · NYSE · Health & bio

41.25USD

+0.16 (+0.39%)11.12 close

AI analysis

Why did it move today?

Written on the first request, then ready instantly for everyone for the rest of the day.

Today in numbers

  • Trading was lighter than usual.

By investing style

Indicators investors with this style usually check

  • Volume vs 20-day avg0.0x
  • vs 20-day average+3.5%
  • Above 52-week low+10.5%

These are explanations of indicators, not buy or sell recommendations. Investment decisions are your own.

Key metrics

Market cap$138.0B
P/E10.1x
P/B5.4x
52-week high50.96
52-week low37.32

What does the company do?

Novo Nordisk is a Danish pharmaceutical company. It is well known for diabetes and obesity treatments. This ADR represents the company's Class B shares.